Literature DB >> 17099352

Cricopharyngeal Botox injection: indications and technique.

Mieke B J Moerman1.   

Abstract

PURPOSE OF REVIEW: Botulinum injection is a widespread technique for treating oropharyngeal dysphagia although there are no standards or guidelines. Based on the literature review we try to make some recommendations. RECENT
FINDINGS: In the last 12 months molecular and pharmacological research has reported the working mechanism of the various botulinum toxin types which tries to explain former clinical observations such as variable response rate and therefore dosage, and toxin type specific resistance. Recent dose-ranging studies or comparisons of different toxin preparations or types rarely focus on oropharyngeal dysphagia.
SUMMARY: Injection of botulinum toxin A should be considered in cases of relative hypertonicity of the cricopharyngeal muscle and has an onset around day 7 and an offset of at least 4 months. The technique is simple and the complication rate is extremely low (7/100). There are some conditions for success: injection in the horizontal part of the cricopharyngeal muscle, and a high enough start dose. Botulinum injection may be preferred over surgical myotomy because of the low risk, low cost and effectiveness of the procedure. Only in cases of BoNT/A resistance should other toxin types be used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099352     DOI: 10.1097/MOO.0b013e328010b85b

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  15 in total

1.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

2.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

3.  Successful treatment of cricopharyngeal dysphagia with bilateral myectomy in a dog.

Authors:  Daniel K Langlois; Bryden J Stanley; Elizabeth A Ballegeer
Journal:  Can Vet J       Date:  2014-12       Impact factor: 1.008

4.  Quality of Life in Treating Persistent Neurogenic Dysphagia with Cricopharyngeal Myotomy.

Authors:  Xiaofeng Jin; Wei Gu; Wuyi Li; Jian Wang
Journal:  Dysphagia       Date:  2019-07-01       Impact factor: 3.438

5.  Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.

Authors:  Elizabeth A Kelly; Ian J Koszewski; Safwan S Jaradeh; Albert L Merati; Joel H Blumin; Jonathan M Bock
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-02       Impact factor: 1.547

Review 6.  Therapeutic intervention in oropharyngeal dysphagia.

Authors:  Rosemary Martino; Timothy McCulloch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

7.  Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage.

Authors:  Eike Krause; Jörg Schirra; Robert Gürkov
Journal:  Dysphagia       Date:  2008-04-24       Impact factor: 3.438

8.  Surgical rehabilitation.

Authors:  G Bergamini; L Presutti; M Alicandri Ciufelli; F Masoni
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-10-05       Impact factor: 2.124

9.  Long-term results of external upper esophageal sphincter myotomy for oropharyngeal Dysphagia.

Authors:  Martijn P Kos; Eric F David; Elly C Klinkenberg-Knol; Hans F Mahieu
Journal:  Dysphagia       Date:  2009-09-17       Impact factor: 3.438

10.  Validity and reliability of a novel patient reported outcome tool to evaluate post-operative dysphagia, odynophagia, and voice (DOV) disability after anterior cervical procedures.

Authors:  Joseph A Sclafani; Deborah I Ross; Brian H Weeks; Michelle Yang; Choll W Kim
Journal:  Int J Spine Surg       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.